Roche sticks to price in extended Illumina offer
ZURICH (Reuters) - Roche extended its $5.7 billion hostile cash bid for U.S. gene decoder Illumina on Monday, showing the Swiss drugmaker's willingness to play a waiting game, an M&A strategy that has paid off in the past.
Source : reuters.com
|
|
 Twitter
Copy link
Link copied!
|
New Assay on AcuStar Hemostasis Testing System Receives CE Mark
Instrumentation Laboratory (IL), Bedford, MA, announced the release of their new HemosIL AcuStar HIT Panel assay that is also now a European CE IVD Marked...
Source : medgadget.com
|
|
Twitter
Copy link
Link copied!
|
Gen-Probe Inc (GPRO.OQ) Key Developments | Reuters.com
FDA Approves Gen-Probe Incorporated's And DiagnoCure Inc.'s PROGENSA PCA3 Assay, First Urine-Based Molecular Test To Help Determine Need For Repeat Prostate Biopsies
Source : reuters.com
|
|
Twitter
Copy link
Link copied!
|
Alert issued in UK for reagents used with Hitachi lab analyzer | IVD Technology
The Medicines and Healthcare products Regulatory Agency (MHRA), a British regulatory body, has issued an alert for reagents requiring manual handling on Hitachi’s Cobas c501/502 laboratory analyzer.
Source : ivdtechnology.com
|
|
Twitter
Copy link
Link copied!
|
Lost in the euphoria of the 2003 announcement that the human genome had been sequenced was a fundamental question: how can we be sure that an individual's genome has been read correctly?
|
|
Twitter
Copy link
Link copied!
|
GEN | News Highlights:Vela, Anagnostics to Offer Cylinder-Based DNA/Protein Microarray Platform
Companies will exploit Anagnostics’ hybcell platform for diagnostics and drug development.
Source : genengnews.com
|
|
Twitter
Copy link
Link copied!
|
Siemens Partners with ViiV Healthcare, Tocagen on Companion Diagnostics | IVD Technology
Siemens Healthcare Diagnostics announced two new companion diagnostics partnerships with pharmaceutical companies ViiV Healthcare and Tocagen, marking a major step for Siemens into this important and fast-growing segment of the IVD market.
Source : ivdtechnology.com
|
|
Twitter
Copy link
Link copied!
|
Illumina rejette l'offre de Roche, jugée inadéquate
Illumina a rejeté l'offre hostile de 5,7 milliards de dollars (4,3 milliards d'euros) du laboratoire pharmaceutique...
Source : lesechos.fr
|
|
Twitter
Copy link
Link copied!
|
Applied Proteomics, Inc. Taps New CEO, Raises $22.5 Million
SAN DIEGO, Feb. 7, 2012 /PRNewswire/ -- Applied Proteomics Inc. (API), powering the proteome to transform diagnostics, announced today the appointment of veteran diagnostic developer, Peter Klemm, Ph.D., as chief executive officer.
Source : devicespace.com
|
|
Twitter
Copy link
Link copied!
|
|
Nanostart Holding Lumiphore Announces European Launch of Diagnostic Tests
Nanostart holding Lumiphore announced the European launch of three diagnostic tests by its partner ThermoFisher Scientific Clinical Diagnostics using Lumiphore's time-resolved fluorescent reporter technology. ThermoFisher Clinical Diagnostics has launched three CE-marked in vitro diagnostic tests in countries of the European Economic Area (EEA)
Source : nanowerk.com
|
|
Twitter
Copy link
Link copied!
|
Oxford Nanopore To Sell Tiny DNA Sequencer
Oxford Nanopore Technologies Ltd. is entering the gene-sequencing race with a new portable device that will allow people to analyze DNA on the go.
Source : bloomberg.com
|
|
Twitter
Copy link
Link copied!
|
OCD's "Know Your Numbers" campaign pushes forward | IVD Technology
USA : Ortho Clinical Diagnostics (OCD), in partnership with the National Association of Chronic Disease Directors (NACDD), published consumer-survey results and a report revealing the state of blood test health literacy in the United States, with...
Source : ivdtechnology.com
|
|
Twitter
LinkedIn
Copy link
Link copied!
|
Glaxo, Takeda Unlikely to Build In-House Diagnostic Units - Businessweek
GlaxoSmithKline Plc and Takeda Pharmaceutical Co. Ltd. said they are unlikely to build in-house diagnostic divisions like Roche Holding AG, which is bidding to take over a U.S. maker of gene-mapping tools.Pfizer and Sanofi add comments.
Source : businessweek.com
|
|
Twitter
Copy link
Link copied!
|
Cette grande étude nationale américaine conclut - à nouveau- que les tests ADN de détection des anomalies foetales par biopuces chromosomiques (CMA- chromosomal microarray) apportent plus de résultats sur les anomalies possibles que la méthode standard de dépistage prénatal, par caryotype, c’est-à-dire par examen au microscope des chromosomes d'une cellule. Les résultats de cette étude clinique, financée par l’Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH), viennent d’être présentés à Dallas, lors de la 32e réunion annuelle de la Society for Maternal-Fetal Medicine et d’être publiés dans l’édition du de l’American Journal of Obstetrics & Gynecology.
|
|
Twitter
Copy link
Link copied!
|
Eucomed - Industry supports European Commission in strengthening medical devices legislation
Brussels, 9 February 2012 – The European medical technology industry recognises the need to improve the effectiveness of the current European regulatory framework for medical devices. Eucomed, the European industry association for medical technology, appreciates the European Commission’s swift reaction and clear proposal for a joint plan of immediate measures to strengthen the European medical devices legislation. After analysing the Commission’s proposal, Eucomed believes the measures are balanced and appropriate and will have a positive effect on patient safety.
Source : eucomed.org
|
|
Twitter
Copy link
Link copied!
|
Industry associations discuss mutually important issues | IVD Technology
Last October, the European Diagnostic Manufacturers Association (EDMA; Brussels) hosted the European IVD Forum 2011. The forum was attended by members of the IVD industry, key policymakers from European and national institutions, and representatives from patient and professional healthcare groups.
Source : ivdtechnology.com
|
|
 Facebook
Twitter
Copy link
Link copied!
|
Roche poursuit son expansion - Courrier Laval
Courrier LavalRoche poursuit son expansionCourrier LavalRoche Diagnostics Canada opère son siège social à Laval, au coeur même de la Cité de la biotechnologie et de la santé humaine du Montréal métropolitain.
Source : courrierlaval.com
|
|
Twitter
Copy link
Link copied!
|
Siemens AG Signs First Personalized Medicine Diagnostics Deals
Siemens AG, Europes largest engineering company, is wading into the multibillion-dollar field of personalized medicine by announcing deals to develop companion tests with two drugmakers.
Source : devicespace.com
|
|
Twitter
Copy link
Link copied!
|
|
